Neurogene Inc. Shares Outstanding (Cover Page)
Neurogene Inc. (NGNE) had Shares Outstanding (Cover Page) of 20.01 million shares as of 2026-08-07, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-07: Entity Common Stock, Shares Outstanding 20.01M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 15.80M shares.
- 2026-03-18: Entity Common Stock, Shares Outstanding 15.57M shares.
- 2025-11-11: Entity Common Stock, Shares Outstanding 15.49M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-07 | 20.01M shares 10-Q · filed 2026-08-11 |
| 2026-05-08 | 15.80M shares 10-Q · filed 2026-05-12 |
| 2026-03-18 | 15.57M shares 10-K · filed 2026-03-24 |
| 2025-11-11 | 15.49M shares 10-Q · filed 2025-11-13 |
| 2025-08-06 | 14.27M shares 10-Q · filed 2025-08-11 |
| 2025-05-05 | 14.26M shares 10-Q · filed 2025-05-09 |
| 2025-03-18 | 14.93M shares 10-K · filed 2025-03-24 |
| 2024-11-13 | 14.85M shares 10-Q · filed 2024-11-18 |
| 2024-08-05 | 12.99M shares 10-Q · filed 2024-08-09 |
| 2024-05-06 | 12.98M shares 10-Q · filed 2024-05-10 |
| 2024-03-13 | 12.85M shares 10-K · filed 2024-03-18 |
| 2023-11-10 | 9.40M shares 10-Q · filed 2023-11-14 |
| 2023-08-08 | 44.02M shares 10-Q · filed 2023-08-10 |
| 2023-05-04 | 42.83M shares 10-Q · filed 2023-05-08 |
| 2023-03-16 | 42.82M shares 10-K · filed 2023-03-20 |
| 2022-11-11 | 42.59M shares 10-Q · filed 2022-11-14 |
| 2022-08-05 | 42.58M shares 10-Q · filed 2022-08-09 |
| 2022-05-06 | 42.50M shares 10-Q · filed 2022-05-09 |
| 2022-02-28 | 42.49M shares 10-K · filed 2022-03-01 |
| 2021-11-03 | 42.43M shares 10-Q · filed 2021-11-04 |
| 2021-08-03 | 42.43M shares 10-Q · filed 2021-08-05 |
| 2021-05-10 | 42.35M shares 10-Q · filed 2021-05-12 |
| 2021-03-22 | 42.33M shares 10-K · filed 2021-03-25 |
| 2020-11-04 | 41.89M shares 10-Q · filed 2020-11-09 |
| 2020-08-07 | 41.75M shares 10-Q · filed 2020-08-12 |
| 2020-05-04 | 38.49M shares 10-Q · filed 2020-05-06 |
| 2020-03-12 | 38.37M shares 10-K · filed 2020-03-12 |
| 2019-11-13 | 38.33M shares 10-Q · filed 2019-11-13 |
| 2019-08-01 | 23.54M shares 10-Q · filed 2019-08-01 |
| 2019-05-07 | 23.54M shares 10-Q · filed 2019-05-07 |
| 2019-03-07 | 23.54M shares 10-K · filed 2019-03-07 |
| 2018-11-07 | 23.54M shares 10-Q · filed 2018-11-07 |
| 2018-08-08 | 23.54M shares 10-Q · filed 2018-08-08 |
| 2018-05-08 | 23.51M shares 10-Q · filed 2018-05-08 |
| 2018-03-09 | 23.49M shares 10-K · filed 2018-03-12 |
| 2017-11-08 | 23.46M shares 10-Q · filed 2017-11-08 |
| 2017-08-08 | 23.46M shares 10-Q · filed 2017-08-08 |
| 2017-05-09 | 23.42M shares 10-Q · filed 2017-05-09 |
| 2017-03-09 | 23.42M shares 10-K · filed 2017-03-09 |
| 2016-11-09 | 23.42M shares 10-Q · filed 2016-11-09 |
| 2016-08-04 | 17.21M shares 10-Q · filed 2016-08-04 |
| 2016-05-09 | 17.21M shares 10-Q · filed 2016-05-10 |
| 2016-03-10 | 17.21M shares 10-K · filed 2016-03-14 |
| 2015-11-09 | 17.21M shares 10-Q · filed 2015-11-10 |
| 2015-08-05 | 10.73M shares 10-Q · filed 2015-08-06 |
| 2015-05-04 | 10.72M shares 10-Q · filed 2015-05-12 |
| 2015-03-12 | 10.72M shares 10-K · filed 2015-03-16 |
| 2014-11-03 | 10.70M shares 10-Q · filed 2014-11-04 |
| 2014-08-07 | 10.70M shares 10-Q · filed 2014-08-11 |
| 2014-04-30 | 10.68M shares 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |